Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance DUBLIN, May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. "I am proud of the continued strong execution across each of Endo's business segments as reflected by our better than expected first-quarter 2021 results. During the quarter, our Branded Pharmaceuticals segment returned to growth, driven by strong demand for XIAFLEX and other physician administered products," said Blaise Coleman, President and Chief Executive Officer at Endo. "In addition, we continued executing against our ongoing business transformation initiatives and achieved an important strategic milestone with the launch of QWO